Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

NMPA Approval

Dapagliflozin and Metformin Hydrochloride Sustained-release Tablets (Ⅱ)

Approval Number

国药准字H20244864

Company江苏宣泰药业有限公司

Registration Date

September 10, 2024

Drug Information

Generic Name

达格列净二甲双胍缓释片(Ⅱ)

Dosage Form

片剂

Strength

达格列净2.5mg（以C₂₁H₂₅ClO₆计）和盐酸二甲双胍1000mg。

Drug Type

化学药品

Registration Date

September 10, 2024

Company Information

Applicant Company

Company Name江苏宣泰药业有限公司

Company Address

南通市海门区滨江街道珠海路163号

Manufacturing Company

Company Name江苏宣泰药业有限公司

Company Address

南通市海门区滨江街道珠海路163号

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy